Stefan D. Anker

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction”.

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Circulation(2020)10.1161/circulationaha.120.051783

N/A

7.6DataRank · unranked

429 citations

Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock +14 more

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension(2022)10.1161/hypertensionaha.122.19744

N/A

2.1DataRank · unranked

98 citations

Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing +8 more

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal(2022)10.1093/ckj/sfac234

N/A

2.0DataRank · unranked

102 citations

Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos +12 more

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab336

N/A

1.7DataRank · unranked

62 citations

Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope +12 more

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

European Heart Journal - Cardiovascular Pharmacotherapy(2023)10.1093/ehjcvp/pvad001

N/A

1.3DataRank · unranked

39 citations

Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky +13 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0.770DataRank · unranked

169 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines

The journal of nutrition health & aging(2021)10.1007/s12603-021-1665-8

N/A

0DataRank · unranked

1179 citations

Reshma Aziz Merchant, John E. Morley, Stefan D. Anker, Iván Aprahamian, Hidenori Arai +31 more

Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF

JACC Heart Failure(2022)10.1016/j.jchf.2021.12.004

N/A

0DataRank · unranked

63 citations

Matthew W. Segar, Muhammad Usman, Sumitabh Singh, Stephen J. Greene, Gregg C. Fonarow +6 more

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal(2021)10.1093/eurheartj/ehab777

N/A

0DataRank · unranked

1207 citations

Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph +7 more

Recurrent Events in Cardiovascular Trials

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.07.024

N/A

0DataRank · unranked

45 citations

Gregg W. Stone, Deepak L. Bhatt, Milton Packer, Stefan D. Anker, Cordula Zeller +3 more

Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

Journal of Cardiac Failure(2020)10.1016/j.cardfail.2020.02.001

N/A

0DataRank · unranked

102 citations

Muhammad Shahzeb Khan, Stefan D. Anker, Gregg C. Fonarow, Raymond J. Kim, Savina Nodari +11 more

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

JAMA Cardiology(2023)10.1001/jamacardio.2023.1505

N/A

0DataRank · unranked

35 citations

Bertram Pitt, Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Luís M. Ruilope +10 more

Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps

Journal of Cachexia Sarcopenia and Muscle(2023)10.1002/jcsm.13355

N/A

0DataRank · unranked

24 citations

Andrew J.S. Coats, John E. Morley, Tatiana Klompenhouwer, Stefan D. Anker, the International Advisory Board, and Regional Advisory Boards for North America, Latin America, Europe and Japan +1 more

Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00291-7

N/A

0DataRank · unranked

5 citations

Stefan D. Anker, Javed Butler, George L. Bakris, Deepak L. Bhatt, Gregg C. Fonarow +2 more

Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020

American Heart Journal(2024)10.1016/j.ahj.2024.09.002

N/A

0DataRank · unranked

10 citations

Arsalan Hamid, Huzaifa Ul Haq Ansari, Michel G. Khouri, Markus S. Anker, Michael E. Hall +4 more

Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

European Journal of Heart Failure(2025)10.1002/ejhf.3673

N/A

0DataRank · unranked

16 citations

Alexandre Mebazaa, Dimitrios Farmakis, Magdy Abdelhamid, Lars H. Lund, Veli‐Pekka Harjola +36 more

Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction

Nature Cardiovascular Research(2025)10.1038/s44161-025-00657-7

N/A

0DataRank · unranked

3 citations

Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones +8 more

Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2022.03.353

N/A

0DataRank · unranked

101 citations

W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Stefan D. Anker, Deepak L. Bhatt +3 more

Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

ESC Heart Failure(2025)10.1002/ehf2.15393

N/A

0DataRank · unranked

1 citations

Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington +19 more